BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Diagnosis
21 results:

  • 1. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
    Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
    World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study.
    Nacer DF; Vallon-Christersson J; Nordborg N; Ehrencrona H; Kvist A; Borg Å; Staaf J
    Genome Med; 2023 Apr; 15(1):25. PubMed ID: 37060015
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?
    Abdelazeem B; Abbas KS; Shehata J; El-Shahat NA; Eltaras MM; Qaddoumi I; Alfaar AS
    Cancer Med; 2023 Mar; 12(5):6318-6324. PubMed ID: 36479934
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy of a Deep Learning Convolutional Neural Network System for Melanoma diagnosis in a Hospital Population.
    Martin-Gonzalez M; Azcarraga C; Martin-Gil A; Carpena-Torres C; Jaen P
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409575
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A two-stage network with prior knowledge guidance for medullary thyroid carcinoma recognition in ultrasound images.
    Pan L; Cai Y; Lin N; Yang L; Zheng S; Huang L
    Med Phys; 2022 Apr; 49(4):2413-2426. PubMed ID: 35103313
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Assessment of deep neural networks for the diagnosis of benign and malignant skin neoplasms in comparison with dermatologists: A retrospective validation study.
    Han SS; Moon IJ; Kim SH; Na JI; Kim MS; Park GH; Park I; Kim K; Lim W; Lee JH; Chang SE
    PLoS Med; 2020 Nov; 17(11):e1003381. PubMed ID: 33237903
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
    Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
    J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Usefulness of neuron-specific enolase as a serum marker of metastatic melanoma.
    Sato S; Kato J; Sawada M; Horimoto K; Okura M; Hida T; Uhara H
    J Dermatol; 2020 Oct; 47(10):1141-1148. PubMed ID: 32734632
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Screening for Pineal Trilateral Retinoblastoma Revisited: A Meta-analysis.
    de Jong MC; Kors WA; Moll AC; de Graaf P; Castelijns JA; Jansen RW; Gallie B; Soliman SE; Shaikh F; Dimaras H; Kivelä TT
    Ophthalmology; 2020 May; 127(5):601-607. PubMed ID: 32061409
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic factors of patients with Gliomas - an analysis on 335 patients with Glioblastoma and other forms of Gliomas.
    Liang J; Lv X; Lu C; Ye X; Chen X; Fu J; Luo C; Zhao Y
    BMC Cancer; 2020 Jan; 20(1):35. PubMed ID: 31941467
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Validation of an integrated dermoscopic scoring method in an European teledermoscopy web platform: the iDScore project for early detection of melanoma.
    Tognetti L; Cevenini G; Moscarella E; Cinotti E; Farnetani F; Lallas A; Tiodorovic D; Carrera C; Puig S; Perrot JL; Longo C; Argenziano G; Pellacani G; Smargiassi E; Cataldo G; Cartocci A; Balistreri A; Rubegni P
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):640-647. PubMed ID: 31465600
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?
    Pitre LD; Linford G; Pond GR; McWhirter E; Seow H
    J Cutan Med Surg; 2019; 23(6):586-594. PubMed ID: 31462069
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas.
    Karlberg A; Berntsen EM; Johansen H; Skjulsvik AJ; Reinertsen I; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    Clin Nucl Med; 2019 Jul; 44(7):550-559. PubMed ID: 31107743
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.
    Schreckenbach T; Hübert H; Koch C; Bojunga J; Schnitzbauer AA; Bechstein WO; Holzer K
    Eur J Surg Oncol; 2019 May; 45(5):808-815. PubMed ID: 30611565
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Findings of DTI-p maps in comparison with T
    Beigi M; Safari M; Ameri A; Moghadam MS; Arbabi A; Tabatabaeefar M; SalighehRad H
    Cancer Imaging; 2018 Sep; 18(1):33. PubMed ID: 30227891
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
    Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
    Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.
    Stensjøen AL; Berntsen EM; Jakola AS; Solheim O
    Clin Neurol Neurosurg; 2018 Jul; 170():38-42. PubMed ID: 29727799
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long-term survivors of glioblastoma: a closer look.
    Gately L; McLachlan SA; Philip J; Ruben J; Dowling A
    J Neurooncol; 2018 Jan; 136(1):155-162. PubMed ID: 29079955
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An update on novel mechanisms of primary aldosteronism.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).
    Lebbe C; Lorigan P; Ascierto P; Testori A; Bédane C; Middleton M; van Baardewijk M; Konto C; Dueymes A; Maio M
    Eur J Cancer; 2012 Nov; 48(17):3205-14. PubMed ID: 22742880
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.